ESSILORLUXOTTICA

EPA-EL
Euronext Paris
Healthcare Medical Instruments & Supplies
Global Rank
#141
Country Rank
#7
Market Cap
128.46 B
Price
275.99
Change (%)
0.88%
Volume
49,417

ESSILORLUXOTTICA's latest marketcap:

128.46 B

As of 06/26/2025, ESSILORLUXOTTICA's market capitalization has reached $128.46 B. According to our data, ESSILORLUXOTTICA is the 141th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 128.46 B
Revenue (ttm) 31 B
Net Income (ttm) 2.76 B
Shares Out 461.35 M
EPS (ttm) 6
Forward PE 31.28
Ex-Dividend Date 05/07/2025
Earnings Date 07/28/2025
Market Cap Chart
Data Updated: 06/26/2025

ESSILORLUXOTTICA's yearly market capitalization.

ESSILORLUXOTTICA has seen its market value grow from €19.54 B to €128.46 B since 2014, representing a total increase of 557.40% and an annual compound growth rate (CAGR) of 19.67%.
Date Market Cap Change (%) Global Rank
06/26/2025 €128.46 B 3.42% 141
12/31/2024 €107.38 B 31.01% 147
12/29/2023 €81.96 B 8.94% 166
12/30/2022 €75.24 B -8.92% 165
12/31/2021 €82.61 B 48.44% 166
12/31/2020 €55.65 B -5.33% 214
12/31/2019 €58.78 B 26.08% 176
12/31/2018 €46.62 B 89.18% 176
12/29/2017 €24.65 B 7.4% 430
12/30/2016 €22.95 B -5.71% 423

Company Profile

Company Overview

EssilorLuxottica Société anonyme is a global leader in designing, manufacturing, and distributing ophthalmic lenses, frames, and sunglasses. Operating across North America, the Middle East, Africa, Europe, Latin America, and the Asia-Pacific, the company serves a diverse customer base through innovative eyewear solutions.

Product Offerings

  • Lenses & Eyewear: Offers a wide range of products under renowned brands such as Essilor, Varilux, Crizal, Ray-Ban, Oakley, Persol, and Foster Grant.
  • Vision Care Solutions: Provides contact lenses, reading glasses, and specialized eyewear under brands like Eyezen, Stellest, and Xperio.
  • Medical & Diagnostic Equipment: Includes platforms like SPECTRALIS, ANTERION, and HEYEX 2 for eye pathology diagnosis, imaging, and electronic medical records.
  • Manufacturing & Tools: Supplies high-tech optical surfacing equipment, consumables, and services under the Satisloh brand.

Market Presence

The company distributes its products through:

  • Independent opticians and distributors
  • Third-party e-commerce platforms
  • Large retail chains in the eyecare industry
  • Direct-to-consumer channels via brick-and-mortar stores and online platforms

History & Headquarters

Originally founded in 1849 as Essilor International Société Anonyme, the company rebranded to EssilorLuxottica Société anonyme in October 2018. Its headquarters are located in Paris, France.

Frequently Asked Questions

  • What is ESSILORLUXOTTICA's (EPA-EL) current market cap?
    As of 06/26/2025, ESSILORLUXOTTICA (including the parent company, if applicable) has an estimated market capitalization of $128.46 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • ESSILORLUXOTTICA global market capitalization ranking is approximately 141 as of 06/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.